Bone Grafts and Substitutes Market by Type (Allograft, Bone Graft Substitutes, and Cell-based Matrices) and Application (Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, and Dental Bone Grafting) - Global Opportunity Analysis and Industry Forecast, 2018-2025
The global bone grafts and substitutes market was valued at $2,690 million in 2017, and is expected to reach $3,912 million by 2025 with a CAGR of 4.8% during the forecast period. Bone grafts are implantable materials, which promote bone healing through their osteoconductive, osteogenic, and osteoinductive mechanisms. Bone grafts are used in surgical procedures such as spinal fusion surgeries, bone replacement, ensuring new bone formation, and repair of bone fractures. Moreover, they are applicable in treatment of various bone-related disorders such as congenital pseudoarthrosis, dental bone grafting problems, and complex fractures. Allografts, synthetic bone grafts, and demineralized bone matrix are the most commonly used bone grafts worldwide.
Rise in incidence of musculoskeletal disorders, development of biocompatible synthetic bone grafts, technological advancements in medical field leading to a shift from autograft to allograft drive the growth of the global bone grafts and substitutes market. According to the National Health Interview Survey, in 2012, around 126 million adults were affected by musculoskeletal disorders in the U.S. These estimates are expected to boost the demand for bone grafts and its substitutes in the coming years. In addition, increase in cases of lifestyle disorders such as diabetes and obesity add to the risk of developing degenerative joint diseases that further fuels the growth of the market.
However, high cost of surgeries and ethical issues related with bone grafting procedures restrict the market growth. On the contrary, growth prospects in the emerging markets, rise in interests of key players toward R&D activities in bone grafts & its substitutes, and increase in demand for orthopedic procedures particularly in geriatric population are expected to provide lucrative opportunities for growth of the market in near future.
The report segments the market based upon product, application, and region. Depending on product, the market is fragmented into allografts, bone graft substitutes, and cell-based matrices. The allografts segment is further categorized into machined allografts and demineralized bone matrix. The bone graft substitutes segment is subdivided into bone morphogenic proteins (BMP) and synthetic bone grafts. By application, the market is classified into spinal fusion, trauma, craniomaxillofacial, joint reconstruction, and dental bone grafting. Region wise, it is studied across four major regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
By Type
Rise in incidence of musculoskeletal disorders, development of biocompatible synthetic bone grafts, technological advancements in medical field leading to a shift from autograft to allograft drive the growth of the global bone grafts and substitutes market. According to the National Health Interview Survey, in 2012, around 126 million adults were affected by musculoskeletal disorders in the U.S. These estimates are expected to boost the demand for bone grafts and its substitutes in the coming years. In addition, increase in cases of lifestyle disorders such as diabetes and obesity add to the risk of developing degenerative joint diseases that further fuels the growth of the market.
However, high cost of surgeries and ethical issues related with bone grafting procedures restrict the market growth. On the contrary, growth prospects in the emerging markets, rise in interests of key players toward R&D activities in bone grafts & its substitutes, and increase in demand for orthopedic procedures particularly in geriatric population are expected to provide lucrative opportunities for growth of the market in near future.
The report segments the market based upon product, application, and region. Depending on product, the market is fragmented into allografts, bone graft substitutes, and cell-based matrices. The allografts segment is further categorized into machined allografts and demineralized bone matrix. The bone graft substitutes segment is subdivided into bone morphogenic proteins (BMP) and synthetic bone grafts. By application, the market is classified into spinal fusion, trauma, craniomaxillofacial, joint reconstruction, and dental bone grafting. Region wise, it is studied across four major regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis for the period of 2017Ђ“2025 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on products helps to understand the type of devices used to treat musculoskeletal disorders and degenerative joints diseases.
- Comprehensive analysis of all geographical regions help to determine the prevailing opportunities in these regions.
- Key market players and their strategies are analyzed to understand the competitive outlook of the overall market.
- Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.
By Type
- Allograft
- Machined Allograft
- Demineralized Bone Matrix
- Bone Graft Substitute
- Bone Morphogenic Proteins (BMP)
- Synthetic Bone Grafts
- Cell-based Matrices
- Spinal Fusion
- Trauma
- Joint Reconstruction
- Dental Bone Grafting
- Craniomaxillofacial
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Israel
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Arthrex, Inc.
- Baxter International Inc.
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson (DePuy Synthes)
- Medtronic Plc.
- Musculoskeletal Transplant Foundation
- NuVasive, Inc.
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market share analysis, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increasing incidences of musculoskeletal conditions
3.4.1.2. Technological advancements in medical devices leading to a shift from autograft to allograft
3.4.1.3. Development of biocompatible synthetic bone grafts
3.4.1.4. Obesity and diabetes to increase the risk of degenerative joint diseases
3.4.2. Restraints
3.4.2.1. High cost of surgeries
3.4.2.2. Ethical issues related with bone grafting procedures
3.4.3. Opportunities
3.4.3.1. Emerging markets to offer lucrative growth opportunities
3.5. Government Regulations
3.5.1. FDA
3.5.2. Health Canada
3.5.3. CE Mark
3.5.4. Ministry of Health, Labor and Welfare (MHLW)
3.5.5. Therapeutic Goods Administration (TGA)
3.6. Reimbursement Scenario
3.6.1. U.S.
3.6.2. Europe
3.6.3. Asia-Pacific
3.6.4. LAMEA
CHAPTER 4: BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Allografts
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast, by type
4.2.4. Market size and forecast, by region
4.2.5. Market analysis, by country
4.2.6. Demineralized Bone Matrix (DBM)
4.2.6.1. Market size and forecast
4.2.7. Machined Allografts
4.2.7.1. Market size and forecast
4.3. Bone Graft Substitutes
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Market size and forecast, by region
4.3.5. Market analysis, by country
4.3.6. Bone Morphogenic Proteins (BMP)
4.3.6.1. Market size and forecast
4.3.7. Synthetic Bone Grafts
4.3.7.1. Market size and forecast
4.4. Cell Based Matrices (CBM)
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.2.1. Cell based matrices-major products
4.4.3. Market size and forecast, by region
4.4.4. Market size and forecast, by country
4.4.5. Market analysis, by country
CHAPTER 5: BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Spinal Fusion
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Trauma
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Craniomaxillofacial Surgery
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Joint Reconstruction
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Dental Bone Grafting
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
CHAPTER 6: BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast, by country
6.2.3.1. U.S.
6.2.3.1.1. U.S. Bone Grafts and Substitutes Market by Type
6.2.3.1.2. U.S. Bone Grafts and Substitutes Market by Application
6.2.3.2. Canada
6.2.3.2.1. Canada Bone Grafts and Substitutes Market by Type
6.2.3.2.2. Canada Bone Grafts and Substitutes Market by Application
6.2.3.3. Mexico
6.2.3.3.1. Mexico Bone Grafts and Substitutes Market by Type
6.2.3.3.2. Mexico Bone Grafts and Substitutes Market by Application
6.2.4. Market size and forecast, by type
6.2.5. Market size and forecast, by application
6.3. Europe
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany
6.3.3.1.1. Germany Bone Grafts and Substitutes Market by Type
6.3.3.1.2. Germany Bone Grafts and Substitutes Market by Application
6.3.3.2. France
6.3.3.2.1. France Bone Grafts and Substitutes Market by Type
6.3.3.2.2. France Bone Grafts and Substitutes Market by Application
6.3.3.3. Italy
6.3.3.3.1. Italy Bone Grafts and Substitutes Market by Type
6.3.3.3.2. Italy Bone Grafts and Substitutes Market by Application
6.3.3.4. Spain
6.3.3.4.1. Spain Bone Grafts and Substitutes Market by Type
6.3.3.4.2. Spain Bone Grafts and Substitutes Market by Application
6.3.3.5. UK
6.3.3.5.1. UK Bone Grafts and Substitutes Market by Type
6.3.3.5.2. UK Bone Grafts and Substitutes Market by Application
6.3.3.6. Rest of Europe
6.3.3.6.1. Rest of Europe Bone Grafts and Substitutes Market by Type
6.3.3.6.2. Rest of Europe Bone Grafts and Substitutes Market by Application
6.3.4. Market size and forecast, by type
6.3.5. Market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast, by country
6.4.3.1. Japan
6.4.3.1.1. Japan Bone grafts and substitutes market, by type
6.4.3.1.2. Japan Bone grafts and substitutes market, by application
6.4.3.2. China
6.4.3.2.1. China Bone grafts and substitutes market, by type
6.4.3.2.2. China Bone grafts and substitutes market, by application
6.4.3.3. India
6.4.3.3.1. India Bone grafts and substitutes market, by type
6.4.3.3.2. India Bone grafts and substitutes market, by application
6.4.3.4. Australia
6.4.3.4.1. Australia Bone grafts and substitutes market, by type
6.4.3.4.2. Australia Bone grafts and substitutes market, by application
6.4.3.5. South Korea
6.4.3.5.1. South Korea Bone grafts and substitutes market, by type
6.4.3.5.2. South Korea Bone grafts and substitutes market, by application
6.4.3.6. Rest of Asia-Pacific
6.4.3.6.1. Rest of Asia-Pacific Bone grafts and substitutes market, by type
6.4.3.6.2. Rest of Asia-Pacific Bone grafts and substitutes market, by application
6.4.4. Asia-Pacific Bone grafts and substitutes market, by type
6.4.5. Asia-Pacific Bone grafts and substitutes market, by application
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast, by country
6.5.3.1. Brazil
6.5.3.1.1. Brazil bone grafts and substitutes market, by type
6.5.3.1.2. Brazil bone grafts and substitutes market, by application
6.5.3.2. Israel
6.5.3.2.1. Israel bone grafts and substitutes market, by type
6.5.3.2.2. Israel bone grafts and substitutes market, by application
6.5.3.3. Saudi Arabia
6.5.3.3.1. Saudi Arabia bone grafts and substitutes market, by type
6.5.3.3.2. Saudi Arabia bone grafts and substitutes market, by application
6.5.3.4. South Africa
6.5.3.4.1. South Africa bone grafts and substitutes market, by type
6.5.3.4.2. South Africa bone grafts and substitutes market, by application
6.5.3.5. Rest of LAMEA
6.5.3.5.1. Rest of LAMEA bone grafts and substitutes market, by type
6.5.3.5.2. Rest of LAMEA bone grafts and substitutes market, by application
6.5.4. Market size and forecast, by type
6.5.5. Market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. Arthrex, Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.2. Baxter International Inc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.3. Integra LifeSciences Holdings Corporation
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. Johnson & Johnson (DePuy Synthes)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Medtronic Plc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Musculoskeletal Transplant Foundation
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.7. NuVasive, Inc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Stryker Corporation
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Wright Medical Group N.V.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Zimmer Biomet Holdings, Inc.,
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market share analysis, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increasing incidences of musculoskeletal conditions
3.4.1.2. Technological advancements in medical devices leading to a shift from autograft to allograft
3.4.1.3. Development of biocompatible synthetic bone grafts
3.4.1.4. Obesity and diabetes to increase the risk of degenerative joint diseases
3.4.2. Restraints
3.4.2.1. High cost of surgeries
3.4.2.2. Ethical issues related with bone grafting procedures
3.4.3. Opportunities
3.4.3.1. Emerging markets to offer lucrative growth opportunities
3.5. Government Regulations
3.5.1. FDA
3.5.2. Health Canada
3.5.3. CE Mark
3.5.4. Ministry of Health, Labor and Welfare (MHLW)
3.5.5. Therapeutic Goods Administration (TGA)
3.6. Reimbursement Scenario
3.6.1. U.S.
3.6.2. Europe
3.6.3. Asia-Pacific
3.6.4. LAMEA
CHAPTER 4: BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Allografts
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast, by type
4.2.4. Market size and forecast, by region
4.2.5. Market analysis, by country
4.2.6. Demineralized Bone Matrix (DBM)
4.2.6.1. Market size and forecast
4.2.7. Machined Allografts
4.2.7.1. Market size and forecast
4.3. Bone Graft Substitutes
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Market size and forecast, by region
4.3.5. Market analysis, by country
4.3.6. Bone Morphogenic Proteins (BMP)
4.3.6.1. Market size and forecast
4.3.7. Synthetic Bone Grafts
4.3.7.1. Market size and forecast
4.4. Cell Based Matrices (CBM)
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.2.1. Cell based matrices-major products
4.4.3. Market size and forecast, by region
4.4.4. Market size and forecast, by country
4.4.5. Market analysis, by country
CHAPTER 5: BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Spinal Fusion
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Trauma
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Craniomaxillofacial Surgery
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Joint Reconstruction
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Dental Bone Grafting
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
CHAPTER 6: BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast, by country
6.2.3.1. U.S.
6.2.3.1.1. U.S. Bone Grafts and Substitutes Market by Type
6.2.3.1.2. U.S. Bone Grafts and Substitutes Market by Application
6.2.3.2. Canada
6.2.3.2.1. Canada Bone Grafts and Substitutes Market by Type
6.2.3.2.2. Canada Bone Grafts and Substitutes Market by Application
6.2.3.3. Mexico
6.2.3.3.1. Mexico Bone Grafts and Substitutes Market by Type
6.2.3.3.2. Mexico Bone Grafts and Substitutes Market by Application
6.2.4. Market size and forecast, by type
6.2.5. Market size and forecast, by application
6.3. Europe
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany
6.3.3.1.1. Germany Bone Grafts and Substitutes Market by Type
6.3.3.1.2. Germany Bone Grafts and Substitutes Market by Application
6.3.3.2. France
6.3.3.2.1. France Bone Grafts and Substitutes Market by Type
6.3.3.2.2. France Bone Grafts and Substitutes Market by Application
6.3.3.3. Italy
6.3.3.3.1. Italy Bone Grafts and Substitutes Market by Type
6.3.3.3.2. Italy Bone Grafts and Substitutes Market by Application
6.3.3.4. Spain
6.3.3.4.1. Spain Bone Grafts and Substitutes Market by Type
6.3.3.4.2. Spain Bone Grafts and Substitutes Market by Application
6.3.3.5. UK
6.3.3.5.1. UK Bone Grafts and Substitutes Market by Type
6.3.3.5.2. UK Bone Grafts and Substitutes Market by Application
6.3.3.6. Rest of Europe
6.3.3.6.1. Rest of Europe Bone Grafts and Substitutes Market by Type
6.3.3.6.2. Rest of Europe Bone Grafts and Substitutes Market by Application
6.3.4. Market size and forecast, by type
6.3.5. Market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast, by country
6.4.3.1. Japan
6.4.3.1.1. Japan Bone grafts and substitutes market, by type
6.4.3.1.2. Japan Bone grafts and substitutes market, by application
6.4.3.2. China
6.4.3.2.1. China Bone grafts and substitutes market, by type
6.4.3.2.2. China Bone grafts and substitutes market, by application
6.4.3.3. India
6.4.3.3.1. India Bone grafts and substitutes market, by type
6.4.3.3.2. India Bone grafts and substitutes market, by application
6.4.3.4. Australia
6.4.3.4.1. Australia Bone grafts and substitutes market, by type
6.4.3.4.2. Australia Bone grafts and substitutes market, by application
6.4.3.5. South Korea
6.4.3.5.1. South Korea Bone grafts and substitutes market, by type
6.4.3.5.2. South Korea Bone grafts and substitutes market, by application
6.4.3.6. Rest of Asia-Pacific
6.4.3.6.1. Rest of Asia-Pacific Bone grafts and substitutes market, by type
6.4.3.6.2. Rest of Asia-Pacific Bone grafts and substitutes market, by application
6.4.4. Asia-Pacific Bone grafts and substitutes market, by type
6.4.5. Asia-Pacific Bone grafts and substitutes market, by application
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast, by country
6.5.3.1. Brazil
6.5.3.1.1. Brazil bone grafts and substitutes market, by type
6.5.3.1.2. Brazil bone grafts and substitutes market, by application
6.5.3.2. Israel
6.5.3.2.1. Israel bone grafts and substitutes market, by type
6.5.3.2.2. Israel bone grafts and substitutes market, by application
6.5.3.3. Saudi Arabia
6.5.3.3.1. Saudi Arabia bone grafts and substitutes market, by type
6.5.3.3.2. Saudi Arabia bone grafts and substitutes market, by application
6.5.3.4. South Africa
6.5.3.4.1. South Africa bone grafts and substitutes market, by type
6.5.3.4.2. South Africa bone grafts and substitutes market, by application
6.5.3.5. Rest of LAMEA
6.5.3.5.1. Rest of LAMEA bone grafts and substitutes market, by type
6.5.3.5.2. Rest of LAMEA bone grafts and substitutes market, by application
6.5.4. Market size and forecast, by type
6.5.5. Market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. Arthrex, Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.2. Baxter International Inc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.3. Integra LifeSciences Holdings Corporation
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. Johnson & Johnson (DePuy Synthes)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Medtronic Plc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Musculoskeletal Transplant Foundation
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.7. NuVasive, Inc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Stryker Corporation
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Wright Medical Group N.V.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Zimmer Biomet Holdings, Inc.,
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 02. ALLOGRAFT MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 03. ALLOGRAFT MARKET, BY REGION ($MILLION), 2017-2025
TABLE 04. DEMINERALIZED BONE MATRIX MARKET, BY REGION ($MILLION), 2017-2025
TABLE 05. MACHINED ALLOGRAFTS MARKET, BY REGION ($MILLION), 2017-2025
TABLE 06. BONE GRAFTS SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 07. BONE GRAFTS SUBSTITUTES MARKET, BY REGION ($MILLION), 2017-2025
TABLE 08. BONE MORPHOGENETIC PROTEIN, BY REGION ($MILLION), 2017-2025
TABLE 09. SYNTHETIC BONE GRAFTS, BY REGION ($MILLION), 2017-2025
TABLE 10. CELL BASED MATRICES- MAJOR PRODUCTS AND STRATEGIES
TABLE 11. CELL BASED MATRICES MARKET, BY REGION ($MILLION), 2017-2025
TABLE 12. CELL BASED MATRICES MARKET, BY COUNTRY ($MILLION), 2017-2025
TABLE 13. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 14. SPINAL FUSION MARKET, BY REGION ($MILLION), 2017-2025
TABLE 15. TRAUMA MARKET, BY REGION ($MILLION), 2017-2025
TABLE 16. CRANIOMAXILLOFACIAL MARKET BY REGION ($MILLION), 2017-2025
TABLE 17. JOINT RECONSTRUCTION MARKET, BY REGION ($MILLION), 2017-2025
TABLE 18. DENTAL BONE GRAFTING MARKET, BY REGION ($MILLION), 2017-2025
TABLE 19. BONE GRAFT AND SUBSTITUTES MARKET, BY REGION ($MILLION), 2017-2025
TABLE 20. NORTH AMERICA: BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY ($MILLION), 2017-2025
TABLE 21. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 22. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 23. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 24. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 25. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 26. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 27. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 28. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 29. EUROPE BONE GRAFTS AND SUBSTITUTES, BY COUNTRY ($MILLION), 2017-2025
TABLE 30. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 31. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 32. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 33. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 34. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 35. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 36. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 37. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 38. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 39. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 40. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 41. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 42. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 43. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 44. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 45. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 46. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 47. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 48. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 49. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 50. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 51. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 52. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 53. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 54. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 55. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 57. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 58. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 59. LAMEA BONE GRAFTS AND SUBSTITUTES, BY COUNTRY ($MILLION), 2017-2025
TABLE 60. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 61. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 62. ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 63. ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 64. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 65. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 66. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 67. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 68. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 69. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 70. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 71. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 72. ARTHREX: COMPANY SNAPSHOT
TABLE 73. ARTHREX: PRODUCT CATEGORIES
TABLE 74. ARTHREX: PRODUCT PORTFOLIO
TABLE 75. BAXTER: COMPANY SNAPSHOT
TABLE 76. BAXTER: BUSINESS UNITS
TABLE 77. INTEGRA: COMPANY SNAPSHOT
TABLE 78. INTEGRA: OPERATING SEGMENTS
TABLE 79. INTEGRA: PRODUCT PORTFOLIO
TABLE 80. J&J: COMPANY SNAPSHOT
TABLE 81. J&J: OPERATING SEGMENTS
TABLE 82. J&J: PRODUCT PORTFOLIO
TABLE 83. MEDTRONIC: COMPANY SNAPSHOT
TABLE 84. MEDTRONIC: OPERATING SEGMENTS
TABLE 85. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 86. MTF BIOLOGICS: COMPANY SNAPSHOT
TABLE 87. MTF BIOLOGICS: PRODUCT OFFERINGS
TABLE 88. MTF BIOLOGICS: PRODUCT PORTFOLIO
TABLE 89. NUVASIVE: COMPANY SNAPSHOT
TABLE 90. NUVASIVE: PRODUCT LINE
TABLE 91. NUVASIVE: PRODUCT PORTFOLIO
TABLE 92. STRYKER: COMPANY SNAPSHOT
TABLE 93. STRYKER: OPERATING SEGMENTS
TABLE 94. STRYKER: PRODUCT PORTFOLIO
TABLE 95. WRIGHT MEDICAL: COMPANY SNAPSHOT
TABLE 96. WRIGHT MEDICAL: OPERATING SEGMENTS
TABLE 97. WRIGHT MEDICAL: PRODUCT PORTFOLIO
TABLE 98. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 99. ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 100. ZIMMER BIOMET: PRODUCT PORTFOLIO
TABLE 01. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 02. ALLOGRAFT MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 03. ALLOGRAFT MARKET, BY REGION ($MILLION), 2017-2025
TABLE 04. DEMINERALIZED BONE MATRIX MARKET, BY REGION ($MILLION), 2017-2025
TABLE 05. MACHINED ALLOGRAFTS MARKET, BY REGION ($MILLION), 2017-2025
TABLE 06. BONE GRAFTS SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 07. BONE GRAFTS SUBSTITUTES MARKET, BY REGION ($MILLION), 2017-2025
TABLE 08. BONE MORPHOGENETIC PROTEIN, BY REGION ($MILLION), 2017-2025
TABLE 09. SYNTHETIC BONE GRAFTS, BY REGION ($MILLION), 2017-2025
TABLE 10. CELL BASED MATRICES- MAJOR PRODUCTS AND STRATEGIES
TABLE 11. CELL BASED MATRICES MARKET, BY REGION ($MILLION), 2017-2025
TABLE 12. CELL BASED MATRICES MARKET, BY COUNTRY ($MILLION), 2017-2025
TABLE 13. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 14. SPINAL FUSION MARKET, BY REGION ($MILLION), 2017-2025
TABLE 15. TRAUMA MARKET, BY REGION ($MILLION), 2017-2025
TABLE 16. CRANIOMAXILLOFACIAL MARKET BY REGION ($MILLION), 2017-2025
TABLE 17. JOINT RECONSTRUCTION MARKET, BY REGION ($MILLION), 2017-2025
TABLE 18. DENTAL BONE GRAFTING MARKET, BY REGION ($MILLION), 2017-2025
TABLE 19. BONE GRAFT AND SUBSTITUTES MARKET, BY REGION ($MILLION), 2017-2025
TABLE 20. NORTH AMERICA: BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY ($MILLION), 2017-2025
TABLE 21. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 22. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 23. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 24. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 25. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 26. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 27. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 28. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 29. EUROPE BONE GRAFTS AND SUBSTITUTES, BY COUNTRY ($MILLION), 2017-2025
TABLE 30. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 31. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 32. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 33. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 34. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 35. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 36. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 37. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 38. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 39. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 40. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 41. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 42. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 43. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 44. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 45. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 46. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 47. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 48. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 49. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 50. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 51. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 52. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 53. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 54. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 55. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 57. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 58. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 59. LAMEA BONE GRAFTS AND SUBSTITUTES, BY COUNTRY ($MILLION), 2017-2025
TABLE 60. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 61. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 62. ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 63. ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 64. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 65. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 66. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 67. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 68. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 69. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 70. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2017-2025
TABLE 71. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2017-2025
TABLE 72. ARTHREX: COMPANY SNAPSHOT
TABLE 73. ARTHREX: PRODUCT CATEGORIES
TABLE 74. ARTHREX: PRODUCT PORTFOLIO
TABLE 75. BAXTER: COMPANY SNAPSHOT
TABLE 76. BAXTER: BUSINESS UNITS
TABLE 77. INTEGRA: COMPANY SNAPSHOT
TABLE 78. INTEGRA: OPERATING SEGMENTS
TABLE 79. INTEGRA: PRODUCT PORTFOLIO
TABLE 80. J&J: COMPANY SNAPSHOT
TABLE 81. J&J: OPERATING SEGMENTS
TABLE 82. J&J: PRODUCT PORTFOLIO
TABLE 83. MEDTRONIC: COMPANY SNAPSHOT
TABLE 84. MEDTRONIC: OPERATING SEGMENTS
TABLE 85. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 86. MTF BIOLOGICS: COMPANY SNAPSHOT
TABLE 87. MTF BIOLOGICS: PRODUCT OFFERINGS
TABLE 88. MTF BIOLOGICS: PRODUCT PORTFOLIO
TABLE 89. NUVASIVE: COMPANY SNAPSHOT
TABLE 90. NUVASIVE: PRODUCT LINE
TABLE 91. NUVASIVE: PRODUCT PORTFOLIO
TABLE 92. STRYKER: COMPANY SNAPSHOT
TABLE 93. STRYKER: OPERATING SEGMENTS
TABLE 94. STRYKER: PRODUCT PORTFOLIO
TABLE 95. WRIGHT MEDICAL: COMPANY SNAPSHOT
TABLE 96. WRIGHT MEDICAL: OPERATING SEGMENTS
TABLE 97. WRIGHT MEDICAL: PRODUCT PORTFOLIO
TABLE 98. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 99. ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 100. ZIMMER BIOMET: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. MARKET SEGMENTATION- BONE GRAFT AND SUBSTITUTES
FIGURE 02. TOP INVESTMENT POCKETS IN WORLD BONE GRAFTS AND SUBSTTUTES MARKET
FIGURE 03. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2018
FIGURE 04. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 05. MARKET SHARE ANALYSIS: BONE GRAFTS AND SUBSTITUTES, 2017
FIGURE 06. MARKET SHARE ANALYSIS: MACHINED ALLOGRAFTS, 2017
FIGURE 07. MARKET SHARE ANALYSIS: DEMINERALIZED BONE MATRIX, 2017
FIGURE 08. MARKET SHARE ANALYSIS: BONE MORPHOGENIC PROTEINS, 2017
FIGURE 09. MARKET SHARE ANALYSIS: CELL BASED MATRICES, 2017
FIGURE 10. MARKET SHARE ANALYSIS: SYNTHETIC BONE GRAFTS, 2017
FIGURE 11. MARKET DYNAMICS
FIGURE 12. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE
FIGURE 13. COMPARATIVE ANALYSIS OF ALLOGRAFT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF BONE GRAFTS SUBSTITUTES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF CELL BASED MATRICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF SPINAL FUSION MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF TRAUMA MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF CRANIOMAXILLOFACIAL MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF JOINT RECONSTRUCTION MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF DENTAL BONE GRAFTING MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. BAXTER: NET SALES, 2015-2017 ($MILLION)
FIGURE 22. BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2017 (%)
FIGURE 23. BAXTER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 24. INTEGRA: NET SALES, 2015-2017 ($MILLION)
FIGURE 25. INTEGRA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 26. INTEGRA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 27. J&J: REVENUE, 2015-2017 ($MILLION)
FIGURE 28. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 30. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 31. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 32. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 33. NUVASIVE: NET SALES, 2015-2017 ($MILLION)
FIGURE 34. NUVASIVE: REVENUE SHARE BY PRODUCT LINE, 2017 (%)
FIGURE 35. NUVASIVE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 36. STRYKER: NET SALES, 2015-2017 ($MILLION)
FIGURE 37. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 38. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 39. WRIGHT MEDICAL: NET SALES, 2015-2017 ($MILLION)
FIGURE 40. WRIGHT MEDICAL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 41. WRIGHT MEDICAL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 42. ZIMMER BIOMET: NET SALES, 2015-2017 ($MILLION)
FIGURE 43. ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 44. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 01. MARKET SEGMENTATION- BONE GRAFT AND SUBSTITUTES
FIGURE 02. TOP INVESTMENT POCKETS IN WORLD BONE GRAFTS AND SUBSTTUTES MARKET
FIGURE 03. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2018
FIGURE 04. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 05. MARKET SHARE ANALYSIS: BONE GRAFTS AND SUBSTITUTES, 2017
FIGURE 06. MARKET SHARE ANALYSIS: MACHINED ALLOGRAFTS, 2017
FIGURE 07. MARKET SHARE ANALYSIS: DEMINERALIZED BONE MATRIX, 2017
FIGURE 08. MARKET SHARE ANALYSIS: BONE MORPHOGENIC PROTEINS, 2017
FIGURE 09. MARKET SHARE ANALYSIS: CELL BASED MATRICES, 2017
FIGURE 10. MARKET SHARE ANALYSIS: SYNTHETIC BONE GRAFTS, 2017
FIGURE 11. MARKET DYNAMICS
FIGURE 12. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE
FIGURE 13. COMPARATIVE ANALYSIS OF ALLOGRAFT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF BONE GRAFTS SUBSTITUTES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF CELL BASED MATRICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF SPINAL FUSION MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF TRAUMA MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF CRANIOMAXILLOFACIAL MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF JOINT RECONSTRUCTION MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF DENTAL BONE GRAFTING MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. BAXTER: NET SALES, 2015-2017 ($MILLION)
FIGURE 22. BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2017 (%)
FIGURE 23. BAXTER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 24. INTEGRA: NET SALES, 2015-2017 ($MILLION)
FIGURE 25. INTEGRA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 26. INTEGRA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 27. J&J: REVENUE, 2015-2017 ($MILLION)
FIGURE 28. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 30. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 31. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 32. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 33. NUVASIVE: NET SALES, 2015-2017 ($MILLION)
FIGURE 34. NUVASIVE: REVENUE SHARE BY PRODUCT LINE, 2017 (%)
FIGURE 35. NUVASIVE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 36. STRYKER: NET SALES, 2015-2017 ($MILLION)
FIGURE 37. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 38. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 39. WRIGHT MEDICAL: NET SALES, 2015-2017 ($MILLION)
FIGURE 40. WRIGHT MEDICAL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 41. WRIGHT MEDICAL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 42. ZIMMER BIOMET: NET SALES, 2015-2017 ($MILLION)
FIGURE 43. ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 44. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
